CUH Logo

Mobile menu open

Dr Kate Fife - Publications

  • Lawrence, Nicola J.; Martin, Andrew; Davis, Ian D.; Troon, Simon; Sengupta, Shomik; Hovey, Elizabeth; Coskinas, Xanthi; Kaplan, Richard; Smith, Benjamin; Ritchie, Alastair W. S.; Meade, Angela; Goh, Jeffrey; Gurney, Howard; Harrison, Michelle; Fife, Kate; Eisen, Tim; Blinman, Prunella; Stockler, Martin R. ‘Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma’.Kidney Cancer, vol. 4, no. 4, pp. 185-195, 2020

    View publication (opens in a new tab)

    25 Dec 2020

  • Keohane SG, Botting J, Budny PG, Dolan OM, Fife K, Harwood CA, Mallipeddi R, Marsden JR, Motley RJ, Newlands C, Proby C, Rembielak A, Slater DN, Smithson JA, Buckley P, Fairbrother P, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2020 Nov 4. doi: 10.1111/bjd.19621 PMID: 33150585.

    View publication (opens in a new tab)

    04 Nov 2020

  • Fowler JC, King C, Bryant C, Hall MWJ, Sood R, Ong SH, Earp E, Fernandez-Antoran D, Koeppel J, Dentro SC, Shorthouse D, Durrani A, Fife K, Rytina E, Milne D, Roshan A, Mahububani K, Saeb-Parsy K, Hall BA, Gerstung M, Jones PH. Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site. Cancer Discov. 2020 Oct 21. doi: 10.1158/2159-8290.CD-20-1092. Epub ahead of print. PMID: 33087317.

    View publication (opens in a new tab)

    21 Oct 2020

  • Fife K, Bang A. Combined Radiotherapy and New Systemic Therapies - Have We Moved Beyond Palliation? Clin Oncol (R Coll Radiol). 2020 Nov;32(11):758-765. doi: 10.1016/j.clon.2020.07.021. Epub 2020 Aug 27. PMID: 32863071.

    View publication (opens in a new tab)

    27 Aug 2020

  • Hawkins R, Fife K, Hurst M, Wang M, Naicker N, Nolasco S, Eisen T, Matakidou A, Gordon J. Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK. BMC Cancer. 2020 Jul 17;20(1):670. doi: 10.1186/s12885-020-07154-z. PMID: 32680483; PMCID: PMC7368711.

    View publication (opens in a new tab)

    17 Jul 2020

  • Rembielak A, Sykes AJ, Fife K, Challapalli A, Nobes JP. Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic. Clin Oncol (R Coll Radiol). 2020 Jul;32(7):417-419. doi: 10.1016/j.clon.2020.04.014. Epub 2020 May 7. PMID: 32418675; PMCID: PMC7203060.

    View publication (opens in a new tab)

    07 May 2020

  • Fife K. Hedgehog pathway inhibitors come of age. Br J Dermatol. 2020 Jun;182(6):1322-1323. doi: 10.1111/bjd.18737. Epub 2019 Dec 17. PMID: 31849041.

    View publication (opens in a new tab)

    17 Dec 2019

  • Buckley HL, Collinson FJ, Ainsworth G, Poad H, Flanagan L, Katona E, Howard HC, Murden G, Banks RE, Brown J, Velikova G, Waddell T, Fife K, Nathan PD, Larkin J, Powles T, Brown SR, Vasudev NS. PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. BMC Cancer. 2019 Nov 14;19(1):1102. doi: 10.1186/s12885-019-6273-1. PMID: 31727024; PMCID: PMC6854710.

    View publication (opens in a new tab)

    14 Nov 2019